Andrew Radin

Andrew Radin is an accomplished CEO, co-founder, and entrepreneur with an impressive educational and professional background. He studied at both Stanford University and Rochester Institute of Technology, attaining a Bachelor of Science and Master of Science degree. Andrew is an expert in the field of pharmaceuticals and has spent his career working on innovative projects in the biotech industry.

As the CEO and co-founder of twoXAR Pharmaceuticals, Andrew has led the company to success with his visionary leadership and entrepreneurial spirit. The company leverages AI-powered technology to discover and develop new drugs, and Andrew has been instrumental in leading the team to achieve unprecedented success.

Andrew is also a former advisor at SPARK, a renowned program at Stanford University School of Medicine that assists researchers in bringing their medical research to market. Additionally, he formerly served as a member at StartX, an early-stage startup accelerator program in Silicon Valley.

Overall, Andrew Radin is a highly accomplished and respected figure in the field of biotech and pharmaceuticals. His leadership and expertise have been instrumental in advancing groundbreaking work and driving innovation in the industry.